Persistent cocaine use by patients with chronic kidney disease more than doubled their risk for death.
Men with metabolic syndrome or a smoking history had more than triple the risks for persistent moderate to severe nocturia after TURP.
In a meta-analysis, smokers had an 89% greater risk of dying from prostate cancer compared with nonsmokers.
Reduced risk for all-cause, cancer, cardiovascular mortality for adults with 5 vs 0 low-risk factors.
Researchers present evidence supporting their use, and discuss the limits and hazards of use
Study finds metals, including lead, leak from e-cigarette heating coils into inhaled aerosols
Estimated 168,000 never-smoking young people could become daily smokers after starting e-cigs
Nicotine and nicotine-derived nitrosamine ketone enhance mutational susceptibility in human cells.
Men who smoked just one cigarette/day had 46% of excess relative risk of smoking 20/day.
No evidence that varenicline, bupropion, or nicotine replacement increase probability of abstinence.
About 45.1% of cancer deaths and 42% of all incident cancers are linked to modifiable risk factors.
Overall, 15.1% use cigarettes, with higher use among males, older adults, those with lower incomes.
General practitioners less likely to support smoking cessation in patients with cancer than with CHD
Prevalence of oncogenic oral HPV higher in men, rises with number of lifetime oral sexual partners.
People with a healthy behavioral profile also experienced a delay of up to 6 years in the onset of disability.
The FDA is delaying implementation of last year's rules on cigars and electronic cigarettes currently on the market until 2021 and 2022, respectively.
E-cigarette smoking has similar effects as regular cigarette smoking on weight and metabolic parameters, even without nicotine exposure.
Research suggests that both cigarettes and e-cigarettes are tied to an increased risk of bladder cancer.
Patients smoking 1 or more packs of cigarettes per day had a higher risk of death compared with those who smoked less than 1.
Swedish smokeless tobacco (snus) increases insulin resistance and the risk of type 2 diabetes.
Younger age at initiation was associated with increased risk of mortality, highlighting the importance of youth and early-adult smoking on lifetime mortality risk.
The researchers found that kidney function worsened faster in smokers compared to nonsmokers and those who quit.
Reducing the future burden of smoking-related cancers includes implementing innovative new strategies, and strengthening tobacco control policies and programs.
Smokeless tobacco "snus" users have high blood levels of nicotine which promotes cancer progression.
Current smoking was linked with higher risks for lung cancer and upper aerodigestive cancer by 9 and 5 times, respectively.
Study also links smoking with a decreased likelihood of receiving a kidney transplant.
Large prostates and bladder neck sparing also predict longer time to return of continence.
New findings show that current smokers had an 83% higher incidence of rapid renal function decline compared with never smokers.
Fewer prostate cancer deaths may be yet another benefit of smoking cessation.
Likelihood of overall and respiratory-related mortality is increased 41% and 4-fold, respectively.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)